share_log

中國太保：海外監管公告 - 2023年度利潤分配方案公告

CPIC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 28 10:59
Summary by Moomoo AI
中國太保（CPIC）於2024年3月29日宣布，根據2023年度經審計的財務報表，公司擬對外派發每股現金股利人民幣1.02元（含稅），總計分配約人民幣9.81億元。該利潤分配方案尚需提交至股東大會審議。此外，公司表示，此次現金分紅對集團偿付能力充足率無重大影響，並符合監管要求。獨立董事對此分配方案亦表示同意，認為方案有利於公司持續健康發展，並無損害股東利益。該方案已於2024年3月28日的董事會會議中獲得通過。
中國太保（CPIC）於2024年3月29日宣布，根據2023年度經審計的財務報表，公司擬對外派發每股現金股利人民幣1.02元（含稅），總計分配約人民幣9.81億元。該利潤分配方案尚需提交至股東大會審議。此外，公司表示，此次現金分紅對集團偿付能力充足率無重大影響，並符合監管要求。獨立董事對此分配方案亦表示同意，認為方案有利於公司持續健康發展，並無損害股東利益。該方案已於2024年3月28日的董事會會議中獲得通過。
China Taibao (CPIC) announced on March 29, 2024 that according to its audited financial statements for 2023, the company intends to distribute a cash dividend of RMB1.02 per share (tax included) for a total distribution of approximately RMB9.81 billion. The profit distribution plan is still subject to submission to the General Meeting for consideration. In addition, the company said that this cash dividend had no significant impact on the Group's ability to repay and complied with regulatory requirements. THE INDEPENDENT DIRECTORS ALSO AGREE TO THE DISTRIBUTION PLAN, BELIEVING THAT IT IS CONDUCIVE TO THE CONTINUED HEALTHY DEVELOPMENT OF THE COMPANY WITHOUT PREJUDICE TO THE INTERESTS OF SHAREHOLDERS. The plan was approved at the Board meeting on March 28, 2024.
China Taibao (CPIC) announced on March 29, 2024 that according to its audited financial statements for 2023, the company intends to distribute a cash dividend of RMB1.02 per share (tax included) for a total distribution of approximately RMB9.81 billion. The profit distribution plan is still subject to submission to the General Meeting for consideration. In addition, the company said that this cash dividend had no significant impact on the Group's ability to repay and complied with regulatory requirements. THE INDEPENDENT DIRECTORS ALSO AGREE TO THE DISTRIBUTION PLAN, BELIEVING THAT IT IS CONDUCIVE TO THE CONTINUED HEALTHY DEVELOPMENT OF THE COMPANY WITHOUT PREJUDICE TO THE INTERESTS OF SHAREHOLDERS. The plan was approved at the Board meeting on March 28, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more